These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2160162)

  • 1. [Study of cellular immunity and the opioid peptide system in patients with multiple sclerosis].
    Demina TL; Boĭko AN; Rossel's AN; Balashov KE; Popova NF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):19-24. PubMed ID: 2160162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of cellular immunity in multiple sclerosis].
    Demina TL; Boĭko AN; Balashov KE; Pinegin BV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):35-41. PubMed ID: 2524943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced proliferative response to beta-endorphin of phytohemagglutinin-activated lymphocytes from patients with ulcerative colitis.
    Nikolopoulou V; Lafi T; Athanasiadou A; Zoumbos N
    Z Gastroenterol; 1991 Jun; 29(6):283-5. PubMed ID: 1926960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Status of local and general immunity in patients with multiple sclerosis].
    Totolian NA; Skoromets AA; Barbas IM; Smirnov AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):20-2. PubMed ID: 1647617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes from patients with chronic duodenal ulcer disease show enhanced proliferative response to beta-endorphin.
    Nikolopoulou V; Lafi T; Gogos C; Athanassiadou A; Zoumbos N
    Hepatogastroenterology; 1993 Apr; 40(2):116-9. PubMed ID: 8509040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional properties of T-lymphocytes in patients with multiple sclerosis].
    Zleleznova TA; Ierusalimskiĭ AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):19-23. PubMed ID: 2529722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
    Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
    Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subpopulations in gastric cancer. Preoperative evaluation.
    Sanz ML; Crisci CD; Hernández JL; Subirá ML; Voltas J; Zornoza G; Oehling A
    Allergol Immunopathol (Madr); 1978; 6(5):415-22. PubMed ID: 311148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.
    Knight SC; Harding B; Burman S; Mertin J
    Clin Exp Immunol; 1981 Oct; 46(1):61-9. PubMed ID: 7039882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-immunological monitoring of the condition of patients with multiple sclerosis].
    Gusev EI; Demina TL; Boĭko AN; Tatarinova MIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):14-8. PubMed ID: 1326164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in using T-activin in multiple sclerosis patients].
    Gusev EI; Arion VIa; Aristova RA; Ivanokov AN; Tunkel' OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):168-74. PubMed ID: 6608843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presentation of selected studies on the disease picture of multiple sclerosis].
    Schmidt RM; Neumann V; Kissig B; Kuppe G; Ludewig R
    Nervenarzt; 1987 Jul; 58(7):403-12. PubMed ID: 3498125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular immunity indices in lymphogranulomatosis].
    Baĭsogolov GD; Pavlov VV; Konopliannikov AG; Kozlov VM; Kulish IuS
    Sov Med; 1981; (6):29-34. PubMed ID: 6974405
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vivo T-lymphocyte activation in patients with multiple sclerosis].
    Tilbery CP; Atra M; Scheinberg MA
    Rev Paul Med; 1989; 107(3):167-8. PubMed ID: 2634877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.